Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(2)
About
Eris Lifesciences Ltd.
NSE: ERIS
|
BSE: 540596
|
ISIN: INE406M01024
|
Industry: Pharmaceuticals
|
Mid-range Performer
1677.6000
59.60
(
3.68
%)
NSE
Jun 27, 2025
10:29 AM
69.95% Gain from 52W Low
Volume:
174.9K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Eris Lifesciences Ltd.
07 Aug 2023
1677.60
3.68%
Eris Lifesciences (BUY): In-line quarter; margins moving back on track
Buy:
Eris Lifesciences Ltd.
by
BOB Capital Markets Ltd.
Target: 955
Target
BOB Capital Markets Ltd.
Q1 revenue/PAT in line but operating margin ahead of consensus at 36.4% (+395bps YoY)
Eris Lifesciences Ltd. is trading above all available SMAs
More from Eris Lifesciences Ltd.
Recommended
Market trades flat, Embassy Developments acquires Squadron Developers for Rs 456.6 crore
Trendlyne Marketwatch |
27 Jun 2025, 10:24AM
Smallcaps are back on the radar, with promising growth | Screener: Analyst favourites among smallcaps
The Baseline |
26 Jun 2025, 12:56PM
Earnings Call Transcript - Q1FY21 for Eris Lifesciences
|
04 Aug 2020